Therefore, targeting the ANG2/TIE pathway in combination with other cancer therapeutics represents a promising clinical strategy for cancer treatment in which vascular stabilization is necessary to increase drug efficacy and inhibit therapeutic resistance. Here, ANGPT2 is linked to cancer.